rss
Br J Ophthalmol 88:145-151 doi:10.1136/bjo.88.1.145
  • Perspective

Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research

  1. R Donnelly1,
  2. I Idris1,
  3. J V Forrester2
  1. 1School of Medical and Surgical Sciences, University of Nottingham, UK
  2. 2Department of Ophthalmology, University of Aberdeen, UK
  1. Correspondence to: Professor Richard Donnelly Division of Vascular Medicine, University of Nottingham, Derbyshire Royal Infirmary, Derby DE1 2QY, UK; Richard.donnellynottingham.ac.uk
  • Accepted 26 June 2003

Abstract

Translational research in practice: a PKC­β inhibitor for diabetic retinopathy

Footnotes

  • Conflict of interest: RD and JF have received consultancy fees from Eli Lilly & Co for attending meetings of a UK scientific advisory board for ruboxistaurin. II was supported in part through an unrestricted educational grant from Eli Lilly & Co to the University of Nottingham.

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.